Exosomes displaying native EGF enhance doxorubicin's therapeutic efficacy and reduce cardiotoxicity
J Nanobiotechnology. 2026 Jan 27. doi: 10.1186/s12951-025-04002-9. Online ahead of print.ABSTRACTBACKGROUND: Doxorubicin (DOX) is one of the most potent chemotherapeutic agents for cancer treatment. However, its cumulative and often irreversible, life-threatening cardiotoxicity significantly limits

